Sexually transmitted co-infections increase HIV risk: study
By Chantall Van Raay
Bacterial and viral sexually transmitted infections can exacerbate HIV replication in co-infected individuals, found a recent study conducted by a Canadian team of researchers and led by Charu Kaushic, associate professor of Pathology and Molecular Medicine and member of the Michael G. DeGroote Institute for Infectious Disease Research.
“While sexually transmitted infections are associated with increased HIV-1 susceptibility and viral shedding in the genital tract, the mechanisms underlying this association are poorly understood,” said Kaushic about the study that appears online this month in the Journal of Infectious Diseases. “Our research has found that normal response to these infections by the epithelial cells (the cells that line the genital tract) can lead to increased HIV replication in the female reproductive tract.”
Through this study, Victor Ferreira, a graduate student in Kaushic’s lab revealed how bacterial (gonorrhoea) and viral (genital herpes) sexually transmitted infections can increase HIV replication in co-infected individuals, opening new doors of understanding.
“Clinical studies have clearly shown that co-infection with herpes and gonorrhoea makes HIV infection worse and large trials have been conducted to study if controlling these infections can make HIV infection less invasive and less transmissible? The benefit of treating co-infections has not been as impressive as was expected, and this study increases our understanding of why that might be,” Kaushic said. “We discovered that inflammation plays a key role in HIV replication. It’s not necessary that if you control those infections, the inflammation is gone. So it might useful, that in addition to treating these co-infections with antibiotics or antivirals, to control the inflammation and this might be more effective in stopping HIV replication rather than controlling just the infection.”
The study was supported by an Emerging Team Grant on Co-infections from the Canadian Institutes for Health Research and a scholarship to Ferreira from Ontario HIV Treatment Network.
Click here to read the paper.
